“Fluorescently tagged Pro 140 has been used sinc
Post# of 148288
Not in CYDY trials. See the PR below:
https://www.cytodyn.com/investors/news-events...-occupancy
“today announced the completion of development of the Receptor Occupancy Test to measure the expression of CCR5 in HIV and tumor cells that are occupied by leronlimab. Development of this test could more precisely guide CytoDyn in identification of patients at screening for monotherapy.”